PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New pathway identified in Parkinson's through brain imaging

Finding points to existing drugs which may slow progression and potential tests for early detection of the disease

2010-09-13
(Press-News.org) (NEW YORK, NY, September 13, 2010) – A new study led by researchers at Columbia University Medical Center has identified a novel molecular pathway underlying Parkinson's disease and points to existing drugs which may be able to slow progression of the disease.

The pathway involved proteins – known as polyamines – that were found to be responsible for the increase in build-up of other toxic proteins in neurons, which causes the neurons to malfunction and, eventually, die. Though high levels of polyamines have been found previously in patients with Parkinson's, the new study – which appeared in an early online edition of Proceedings of the National Academy of Sciences – is the first to identify a mechanism for why polyamines are elevated in the first place and how polyamines mediate the disease.

The researchers also demonstrated in a mouse model of Parkinson's disease that polyamine-lowering drugs had a protective effect.

"The most exciting thing about the finding is that it opens up the possibility of using a whole class of drugs that is already available," says Scott A. Small, MD, the senior author of the study and Herbert Irving Associate Professor of Neurology in the Sergievsky Center and in the Taub Institute for Research on Alzheimer's Disease and the Aging Brain at Columbia University Medical Center. "Additionally, since polyamines can be found in blood and spinal fluid, this may lead to a test that could be used for early detection of Parkinson's."

Currently, treatments for Parkinson's can help alleviate some of the disease's symptoms, but they cannot prevent the build-up of toxic proteins and the death of neurons caused by the disease. When polyamines were scrutinized decades ago as a potential therapy against cancer, polyamine-lowering drugs were tested and have completed the Phase 1 and 2 safety stages of clinical trials. However, whether the drugs can pass through the blood-brain barrier remains to be determined and further testing will be needed. If the drugs can reduce the level of polyamines in the brain, they may pave the way for a Parkinson's treatment that can slow the disease's progression.

"This research has the potential to progress quickly," says James Beck, PhD, director of research programs at the Parkinson's Disease Foundation, which helped support the research. "Equally exciting are the new avenues of research this study opens, hopefully leading to better treatments for Parkinson's Disease down the road."

Though many cellular defects have been found to cause rare, inherited forms of Parkinson's disease, most cases of Parkinson's are caused by unknown changes inside the brain's neurons.

The researchers used a wide variety of scientific techniques to search for still unidentified defects in the brain. The suite of techniques – which started with high resolution brain imaging – has been used to reveal previously unknown molecules in the brain that worsen Alzheimer's disease.

Imaging Reveals Brainstem Defect in Parkinson's Patients

The success of the technique depends on identifying regions of the brain affected by the disease and comparing them to unaffected regions.

Using high resolution functional magnetic resonance imaging (fMRI), Nicole Lewandowski, PhD, who is currently a post-doctoral research scientist in Dr. Small's lab, identified such regions in the brainstem of patients with Parkinson's. The scans showed that one region of the brainstem was consistently less active in these patients than in healthy control subjects. Also revealed in the scans was a neighboring region that was unaffected by the disease.

Next, using brain tissue from deceased patients with Parkinson's, the researchers looked for proteins that could potentially explain the brainstem imaging differences.

"One such protein we found, called SAT1, stood out," said Dr. Small. "Because SAT1 is known as an enzyme that helps break down polyamines, and previous research had shown that Parkinson's patients have high levels of polyamines in their brains, we hypothesized that SAT1 and polyamines are involved in the development of Parkinson's disease."

Three Experiments Confirm Polyamines Are Pathogenic

To validate the finding, three separate studies – in yeast, mice, and people – were performed.

The yeast studies revealed that polyamines promote the accumulation of a toxic Parkinson's-causing protein in living cells, and not just in test tubes, as was known from previous research. Conducted by Gregory Petsko, PhD, the Gyula and Katica Tauber Professor of Biochemistry and Chemistry and Chair of Biochemistry at Brandeis University and Dagmar Ringe, PhD, the Harold and Bernice Davis Professor of Aging and Neurodegenerative Disease Research at Brandeis, the new studies found that yeast cells, engineered to produce the toxic Parkinson's protein, die more quickly in the presence of increasing polyamine levels. Furthermore, in a screen conducted for mediators of Parkinson's toxins in the lab of Susan Linquist, PhD, professor of biology in the Whitehead Institute for Biomedical Research and Howard Hughes Medical Institute at MIT, other genes related to polyamine transport were identified.

In the mice studies, a link was established among SAT1, polyamines, and Parkinson's toxins in a mammalian brain. These experiments also revealed that drugs that target SAT1 may be able to slow down the progression of Parkinson's disease. Using drugs that increase SAT1 activity and therefore lower polyamine levels, researchers in the lab of Eliezer Masliah, MD, professor of neurosciences and pathology at the UC San Diego School of Medicine, found a decrease in Parkinson's toxins and the damage which they cause within brain regions affected by the disease.

Genetic studies in patients with Parkinson's provided further evidence that polyamines may help drive Parkinson's disease in people. After examining the SAT1 gene in nearly 100 patients with Parkinson's and additional genotyping in a further ~800 subjects (389 PD patients and 408 controls), enrolled in the Genetic Epidemiology of Parkinson's disease study at CUMC, Columbia geneticist Lorraine Clark, PhD, assistant professor of clinical pathology and cell biology, together with Karen Marder, MD, MPH, who is the Sally Kerlin Professor of Neurology in the Sergievsky Center and in the Taub Institute, uncovered a novel genetic variant that was found exclusively in the study's patients with Parkinson's but not in controls.

"Even though the variant was rare in patients with Parkinson's, finding it was surprising and further strengthens the possibility that defects in the polyamine pathway help to trigger the disease," said Dr. Small.

Dr. Small is now testing current polyamine-lowering drugs to see if the compounds can pass through the blood-brain barrier, or if they can be altered to do so. Drugs that pass through the blood-brain barrier can be administered more easily (e.g., they can be taken by mouth) instead of directly infusing them into the brain.

### This work was supported in part by the National Institute of Neurological Disorders and Stroke, the Parkinson's Disease Foundation and Columbia's Irving Institute for Clinical and Translational Research (CTSA).

Authors of the paper are:

Nicole M. Lewandowskia,b, Shulin Juc, Miguel Verbitskya,d, Barbara Rossa, Melissa L. Geddiee, Edward Rockensteinf,g, Anthony Adamef, Alim Muhammada, Jean Paul Vonsattela,h, Dagmar Ringec, Lucien Cotea,i, Susan Lindquiste, Eliezer Masliahf,g, Gregory A. Petskoc, Karen Mardera,i,j, Lorraine N. Clarka,d,h, and Scott A. Smalla,i

Affiliations:

aTaub Institute for Research on Alzheimer's Disease and the Aging Brain, dCenter for Human Genetics, and Departments of bCellular, Molecular, and Biophysical Studies, iNeurology, hPathology, and jPsychiatry, Columbia University College of Physicians and Surgeons, New York, NY 10032

The Taub Institute for Research on Alzheimer's Disease and the Aging Brain at Columbia University Medical Center is a multidisciplinary group that has forged links between researchers and clinicians to uncover the causes of Alzheimer's, Parkinson's and other age-related brain diseases and discover ways to prevent and cure these diseases. It has partnered with the Gertrude H. Sergievsky Center at Columbia University Medical Center which was established by an endowment in 1977 to focus on diseases of the nervous system. The Center integrates traditional epidemiology with genetic analysis and clinical investigation to explore all phases of diseases of the nervous system. For more information about these centers visit: http://www.cumc.columbia.edu/dept/taub/ http://www.cumc.columbia.edu/dept/sergievsky/

Columbia University Medical Center provides international leadership in basic, pre-clinical and clinical research, in medical and health sciences education, and in patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the College of Physicians and Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Established in 1767, Columbia's College of Physicians and Surgeons was the first institution in the country to grant the M.D. degree and is among the most selective medical schools in the country. Columbia University Medical Center is home to the largest medical research enterprise in New York City and state and one of the largest in the United States. For more information, please visit www.cumc.columbia.edu.

END



ELSE PRESS RELEASES FROM THIS DATE:

Wives as the new breadwinners

2010-09-13
Durham, NH—September 13, 2010— During the recent recession in the United States, many industries suffered significant layoffs, leaving individuals and families to revise their spending and rethink income opportunities. Many wives are increasingly becoming primary breadwinners or entering the labor market. A new article in Family Relations tests "the added worker" theory, which suggests wives who are not working may seek work as a substitute for husband's labor if he becomes unemployed, and finds that during a time of economic downturn wives are more likely to enter the ...

Making cookies that are good for your heart

Making cookies that are good for your heart
2010-09-13
VIDEO: Years of research has proven that saturated and trans fats clog arteries, make it tough for the heart to pump and are not valuable components of any diet. Unfortunately, they... Click here for more information. COLUMBIA, Mo. ¬— Years of research has proven that saturated and trans fats clog arteries, make it tough for the heart to pump and are not valuable components of any diet. Unfortunately, they are contained in many foods. Now, a University of Missouri research ...

Obama administration responds to call to action from Concordia researchers

2010-09-13
Montreal / September 13, 2010 – September 21, 2010 marks the one year anniversary of the release of a landmark document produced by researchers at Concordia University. Mobilizing The Will to Intervene (W2I) offers governments practical steps to prevent future genocides and mass atrocities. Produced by researchers with the Montreal Institute for Genocide and Human Rights Studies (MIGS) based at Concordia, the document was presented to the governments of Canada and The United States of America. It has already yielded concrete results. Under President Barack Obama's leadership, ...

Latent HIV infection focus of NIDA's 2010 Avant-Garde Award

2010-09-13
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, announced today that Dr. Eric M. Verdin of the J. David Gladstone Institutes in San Francisco, Calif., has been selected as the 2010 recipient of the NIDA Avant-Garde Award for HIV/AIDS Research for his proposal to study the mechanisms of latent HIV infection. NIDA's annual Avant-Garde award competition, now in its third year, is intended to stimulate high-impact research that may lead to groundbreaking opportunities for the prevention and treatment of HIV/AIDS in drug abusers. Awardees ...

New study reconciles conflicting data on mental aging

2010-09-13
WASHINGTON — A new look at tests of mental aging reveals a good news-bad news situation. The bad news is all mental abilities appear to decline with age, to varying degrees. The good news is the drops are not as steep as some research showed, according to a study published by the American Psychological Association. "There is now convincing evidence that even vocabulary knowledge and what's called crystallized intelligence decline at older ages," said study author Timothy Salthouse, PhD. Longitudinal test scores look good in part because repeat test-takers grow familiar ...

Scientists glimpse dance of skeletons inside neurons

2010-09-13
Scientists at Emory University School of Medicine have uncovered how a structural component inside neurons performs two coordinated dance moves when the connections between neurons are strengthened. The results are published online in the journal Nature Neuroscience, and will appear in a future print issue. In experiments with neurons in culture, the researchers can distinguish two separate steps during long-term potentiation, an enhancement of communication between neurons thought to lie behind learning and memory. Both steps involve the remodeling of the internal ...

CU-Boulder study sheds light on how our brains get tripped up when we're anxious

2010-09-13
A new University of Colorado at Boulder study sheds light on the brain mechanisms that allow us to make choices and ultimately could be helpful in improving treatments for the millions of people who suffer from the effects of anxiety disorders. In the study, CU-Boulder psychology Professor Yuko Munakata and her research colleagues found that "neural inhibition," a process that occurs when one nerve cell suppresses activity in another, is a critical aspect in our ability to make choices. "The breakthrough here is that this helps us clarify the question of what is happening ...

Energy Express focus issue: Thin-film photovoltaic materials and devices

2010-09-13
WASHINGTON, September 13 – Developing renewable energy sources has never been more important, and solar photovoltaic (PV) technologies show great potential in this field. They convert direct sunlight into electricity with little impact on the environment. This field is constantly advancing, developing technologies that can convert power more efficiently and at a lower cost. To highlight breakthroughs in this area, the editors of Energy Express, a bi-monthly supplement to Optics Express, the open-access journal of the Optical Society (OSA), today published a special Focus ...

Over-the-top grass control in sorghum on the horizon

2010-09-13
AMARILLO - Apply today's chemicals to a sorghum crop for grass control and the sorghum will be killed off also. But a solution could be only a few years away if Texas AgriLife Research plots are any indication. Dr. Brent Bean, AgriLife Research and Texas AgriLife Extension Service agronomist, has test plots that demonstrate sorghum hybrids tolerant to herbicides typically associated with grass control. The control is needed not only for annual grass control but also for Johnsongrass, Bean said. Because Johnsongrass is closely related to grain sorghum, herbicides typically ...

Study finds that sorghum bran has more antioxidants than blueberries, pomegranates

2010-09-13
Athens, Ga. - A new University of Georgia study has found that select varieties of sorghum bran have greater antioxidant and anti-inflammatory properties than well-known foods such as blueberries and pomegranates. Researchers measured polyphenolic compounds, which naturally occur in plants to help fight against pests and disease, and found that the black and sumac varieties of sorghum have significant levels of antioxidants. Many fruits also contain these compounds, they said, though sorghum bran may prove to be the richest and cheapest source. "Since most human chronic ...

LAST 30 PRESS RELEASES:

Milky Way-like galaxy M83 consumes high-speed clouds

Study: What we learned from record-breaking 2021 heat wave and what we can expect in the future

Transforming treatment outcomes for people with OCD

Damage from smoke and respiratory viruses mitigated in mice via a common signaling pathway

New software tool could help better understand childhood cancer

Healthy lifestyle linked to lower diverticulitis risk, irrespective of genetic susceptibility

Women 65+ still at heightened risk of cervical cancer caused by HPV

‘Inflammatory’ diet during pregnancy may raise child’s diabetes type 1 risk

Effective therapies needed to halt rise in eco-anxiety, says psychology professor

Nature-friendly farming boosts biodiversity and yields but may require new subsidies

Against the odds: Endometriosis linked to four times higher pregnancy rates than other causes of infertility, new study reveals

Microplastics discovered in human reproductive fluids, new study reveals

Family ties and firm performance: How cousin marriage traditions shape informal businesses in Africa

Novel flu vaccine adjuvant improves protection against influenza viruses, study finds

Manipulation of light at the nanoscale helps advance biosensing

New mechanism discovered in ovarian cancer peritoneal metastasis: YWHAB restriction drives stemness and chemoresistance

New study links blood metabolites and immune cells to increased risk of urolithiasis

Pyruvate identified as a promising therapeutic agent for ulcerative colitis by targeting cytosolic phospholipase A2

New insights into the clinical impact of IKBKG mutations: Understanding the mechanisms behind rare immunodeficiency syndromes

Displays, imaging and sensing: New blue fluorophore breaks efficiency records in both solids and solutions

Sugar, the hidden thermostat in plants

Personality can explain why some CEOs earn higher salaries

This puzzle game shows kids how they’re smarter than AI

Study suggests remembrances of dead played role in rise of architecture in Andean region

Brain stimulation can boost math learning in people with weaker neural connections

Inhibiting enzyme could halt cell death in Parkinson’s disease, study finds

Neurotechnology reverses biological disadvantage in maths learning

UNDER EMBARGO: Neurotechnology reverses biological disadvantage in maths learning

Scientists target ‘molecular machine’ in the war against antimicrobial resistance

Extending classical CNOP method for deep-learning atmospheric and oceanic forecasting

[Press-News.org] New pathway identified in Parkinson's through brain imaging
Finding points to existing drugs which may slow progression and potential tests for early detection of the disease